or
Antimicrobial composition



Bookmark and Share
Document Number
US Patent 3932607
Issued Date
January 13, 1976
Link
Inventors
Map
Abstract
An antimicrobial composition comprising as active ingredients dodecyl-di-(aminoethyl)-glycine and chlorohexidine or salts thereof.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
11
Comments:
no comments yet
Owner
Published
January 13, 1976
Application Number
05/382,815
Filed
July 26, 1973
US Classification
424/52   424/49 424/54 514/564
Int'l Classification
A61K   33/16   (20060101)   A61K   8/43   (20060101)   A61K   8/44   (20060101)   A61K   8/30   (20060101)   A61Q   11/00   (20060101)  
Priority Data
Jul 31, 1972 [SW] 9953/72
USPTO Field of Search
424/319   424/49   424/54   424/52  
Related Patents
4251507 - Process and composition for reducing dental plaque - Owned by Dominion Pharmacal, Inc. (Norwich, NY)

The present invention relates to an improved method for cleansing of human teeth to help reduce and control dental plaque as an aid in preventing dental caries and periodontal disease. In particular, it relates to a viscous composition of particular characteristics and a process for application thereof to accomplish these objectives.

4666896 - Chlorhexidine salts and compositions of same - Owned by Bristol-Myers Company (New York, NY)

The dinalidixate and diphosphanilate salts of chlorhexidine possess antibacterial activity. They exhibit synergism as compared with comparable concentrations of chlorhexidine and the respective free acid. Synergistic compositions comprising a mixture of a chlorhexidine salt with phosphanilic acid or a salt of phosphanilic acid, or with nalidixic acid, or a salt of nalidixic acid are disclosed. Dermatological compositions of such novel salts, and all such mixtures, are provided.

5679711 - Hydroxyl ions as novel therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents - Owned by FHJ Scientific, Inc. (Houston, TX)

The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinal properties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking and revealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoalkanoate salts and substituted N,N-substituted-aminoalkanoate salts.

5514808 - Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions - Owned by FHJ Scientific, Inc (Houston, TX)

The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinal properties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking and revealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoacetate salts and substituted N,N-substituted-aminoacetate salts.

5585391 - Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them - Owned by FHJ Scientific, Inc. (Houston, TX)

The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinal properties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking and revealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoacetate salts and substituted N,N-substituted-aminoacetate salts. The invention includes compositions and methods of treatment using hydroxyl ions and the companion hydroxyl ion modulating compounds. These compositions and methods of treatment provide a wide variety of therapeutic effects including dermal effects (such as wound healing), ocular effects, oral therapeutic effects, ear, nose and throat therapeutic effects and internal therapeutic effects.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us